This dissertation was written as part of the MSc in Bioeconomy: Biotechnology and
Law, at the International Hellenic University.
The work is divided into two large chapters, one concerning the protection of health,
genetic and biometric data under the scope of the General Data Protection Regulation
and the relevant national legal frameworks, from Europe and the United States, and
the second relating to emerging new technologies applicable to the healthcare sector.
The first part provides a definition of this set of data and the way it was handled and
regulated from the prior legislation. In addition, a specific emphasis is given in the
Greek legislation in comparison with other national legal documents from European
countries, as well as the existing provisions for the protection of sensitive data in the
United States.
Secondly, the dissertation aims to provide a comprehensive presentation of new
technologies that are both amongst the most pioneering of the field but also amongst
the most popular and incorporate in the life of a large number of the population, being
either afflicted by a disease or not. Such cases constitute the direct-to-consumer
genetic testing, mobile health applications, robotics, and AI. They are presented in a
way that illustrates the legal provisions that regulate them, deriving from different
parts of the world, like Europe and the US. There is also an examination of the ethical
questions arising from the use of such technological innovations, and both the
international and European point of view on the matter.
Collections
Show Collections
